There are so many different areas that a social worker can help with in a medical practice that they can be more a case manager, pointing patients to resources for financial assistance, looking at their insurance, or helping with disability, said Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties.
There are so many different areas that a social worker can help with in a medical practice that they can be more a case manager, pointing patients to resources for financial assistance, looking at their insurance, or helping with disability, said Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties.
Transcript
As a social worker, how do you fit into the care management team in healthcare?
It actually fits really well in healthcare. As a social worker, there’s so many different areas that you can help with, so you can be more kind of a case manager, pointing to resources to financial assistance, looking at their insurance, helping with disability—things like that. But then also there’s the emotional side where we are licensed mental health professionals and we can assess for depression and anxiety and other emotional concerns and then offer that support of counseling, as well.
Someone with cancer is definitely not isolated from those concerns of anybody else in the world that might be having problems with transportation, or problems with finances, or housing, or depression, or anxiety, or any other host of mental health issues.
As healthcare practices evolve how they deliver care, how has your role within the team changed?
I have, personally, felt and experienced drastic changes in my position here as a social worker. When I started, I was kind of the introduction to the practice: these are the different areas and of the practice and people that you might come in contact with, kind of a general type thing. And then I, on my own regard, said “no, we need to screen for distress, and I need to see what kind of practical issues, social, emotional issues that these people are facing because I can tackle that.” I really started doing a lot more case management type stuff—referrals, resources, that kind of thing.
But as value-based care has been transitioned into our practice we’ve been able to expand these programs and add in patient navigators who can work on barriers to care, who can help with those practical concerns. We’ve added case managers who are monitoring [emergency department] utilization and things like that. And so now, as the social worker, we’re able to work to a fuller capacity to focus on the emotional and focus on the social and helping to adjust to illness or loss and grief or anxiety and depression—other mental health concerns that are directly related and impacted to their cancer diagnosis.
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
2 Commerce Drive
Cranbury, NJ 08512